X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs FDC LTD. - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA FDC LTD. SANOFI INDIA/
FDC LTD.
 
P/E (TTM) x 34.0 26.7 127.5% View Chart
P/BV x 6.8 5.3 128.6% View Chart
Dividend Yield % 1.3 0.9 148.2%  

Financials

 SANOFI INDIA   FDC LTD.
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
FDC LTD.
Mar-14
SANOFI INDIA/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs4,560144 3,177.7%   
Low Rs4,40079 5,569.6%   
Sales per share (Unadj.) Rs1,028.547.6 2,162.3%  
Earnings per share (Unadj.) Rs129.07.6 1,694.8%  
Cash flow per share (Unadj.) Rs186.09.0 2,064.1%  
Dividends per share (Unadj.) Rs68.002.25 3,022.2%  
Dividend yield (eoy) %1.52.0 75.0%  
Book value per share (Unadj.) Rs753.647.5 1,585.4%  
Shares outstanding (eoy) m23.03177.83 13.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.42.3 186.2%   
Avg P/E ratio x34.714.6 237.6%  
P/CF ratio (eoy) x24.112.3 195.1%  
Price / Book Value ratio x5.92.3 254.0%  
Dividend payout %52.729.6 178.3%   
Avg Mkt Cap Rs m103,17419,784 521.5%   
No. of employees `0003.6NA-   
Total wages/salary Rs m3,5921,221 294.3%   
Avg. sales/employee Rs Th6,537.7NM-  
Avg. wages/employee Rs Th991.4NM-  
Avg. net profit/employee Rs Th819.8NM-  
INCOME DATA
Net Sales Rs m23,6868,459 280.0%  
Other income Rs m708394 179.9%   
Total revenues Rs m24,3948,852 275.6%   
Gross profit Rs m5,2812,070 255.1%  
Depreciation Rs m1,313249 527.1%   
Interest Rs m1531 48.4%   
Profit before tax Rs m4,6612,184 213.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-225 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,691606 279.3%   
Profit after tax Rs m2,9701,353 219.5%  
Gross profit margin %22.324.5 91.1%  
Effective tax rate %36.327.7 130.8%   
Net profit margin %12.516.0 78.4%  
BALANCE SHEET DATA
Current assets Rs m15,6734,355 359.9%   
Current liabilities Rs m6,6781,792 372.7%   
Net working cap to sales %38.030.3 125.3%  
Current ratio x2.32.4 96.6%  
Inventory Days Days7644 171.0%  
Debtors Days Days2225 90.5%  
Net fixed assets Rs m8,0983,025 267.7%   
Share capital Rs m230179 128.9%   
"Free" reserves Rs m17,0888,243 207.3%   
Net worth Rs m17,3568,453 205.3%   
Long term debt Rs m011 0.0%   
Total assets Rs m25,40010,557 240.6%  
Interest coverage x311.771.4 436.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.8 116.4%   
Return on assets %11.813.1 89.6%  
Return on equity %17.116.0 106.9%  
Return on capital %26.923.5 114.6%  
Exports to sales %24.513.3 184.0%   
Imports to sales %28.03.3 836.8%   
Exports (fob) Rs m5,8011,126 515.3%   
Imports (cif) Rs m6,627283 2,343.4%   
Fx inflow Rs m7,1451,146 623.4%   
Fx outflow Rs m6,846355 1,926.8%   
Net fx Rs m299791 37.8%   
CASH FLOW
From Operations Rs m3,2261,485 217.3%  
From Investments Rs m-1,555-620 251.0%  
From Financial Activity Rs m-1,818-753 241.6%  
Net Cashflow Rs m-147113 -130.3%  

Share Holding

Indian Promoters % 0.0 68.9 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 4.7 306.4%  
FIIs % 14.6 7.5 194.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 19.0 55.3%  
Shareholders   15,184 23,730 64.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   SUN PHARMA  DR. REDDYS LAB  GSK PHARMA  FULFORD INDIA  MERCK LTD  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Cuts Losses; TCS Up 3%(Closing)

After opening the day in red, share markets in India witnessed volatile trading activity throughout the day but clawed back some gains in the final hours of the trading window.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jun 15, 2018 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS